KLRS
Kalaris Therapeutics, Inc.
Set alert
2.03 USD -0.10 -4.69%
1.97 Day range 2.08
1.80 52-week range 10.98
- YTD
- -75.95%
- 1 year
- -57.17%
- Open
- 1.98
- Prev close
- 2.13
- Mkt cap
- 48.32M
- Vol
- 60.20K
- Avg vol
- 68.90K
- EPS
- -2.02
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.97
- High
- 2.08
Financial health
Altman Z-Score
-2.38 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
0 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B3 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 4
Valuation
P/E -3.0×
FY 2018 5y median -18.9× FY 2025
P/S 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 1.6×
FY 2018 5y median 1.6× FY 2025
P/FCF -3.0×
FY 2018 5y median -117× FY 2025
EV/EBITDA -0.8×
FY 2018 5y median -109× FY 2025
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -33.5%
FY 2018 5y median -0.9% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -55.1%
FY 2018 5y median -51.9% FY 2025
ROIC -41.1%
FY 2018 5y median -41.1% FY 2025
ROA -35.7%
FY 2018 5y median -60.0% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2025
Operating Income 16.5%
FY 2018 FY 2025
EPS (diluted) 75.7%
FY 2018 FY 2025
Free Cash Flow 36.2%
FY 2018 FY 2025
Financial Health
Current Ratio 12.2×
FY 2018 5y median 6.7× FY 2025
Quick Ratio 12.2×
FY 2018 5y median 6.7× FY 2025
Debt / Equity 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA 2.3×
FY 2018 5y median 1.0× FY 2025
Interest Coverage -32.0×
FY 2018 5y median -19.6× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31